Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their ...

Figure 2: ERF is a tumour suppressor, a negative regulator of androgen signalling, and its loss phenocopies TMPRSS2–ERG gain. Figure 3: ERF and TMPRSS2–ERG have opposing effects on the androgen ...

Enerplus Corporation ERF is set to report third-quarter 2022 results on Nov 3, after the closing bell. In the last reported quarter, Enerplus missed the Zacks Consensus Estimate. It outpaced the ...

Most readers would already be aware that Enerplus' (TSE:ERF) stock increased significantly by 15% over the past three months. Since the market usually pay for a company’s long-term fundamentals, we ...

Enerplus Corporation is a Canadian stock that focuses primarily on the Bakken and Marcellus basins. The analyst community is moderately bullish on the stock, with 8 out of 11 covering the stock rating ...